253 related articles for article (PubMed ID: 15522264)
1. Human and animal hepatocytes in vitro with extrapolation in vivo.
O'Brien PJ; Chan K; Silber PM
Chem Biol Interact; 2004 Nov; 150(1):97-114. PubMed ID: 15522264
[TBL] [Abstract][Full Text] [Related]
2. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships for halobenzene induced cytotoxicity in rat and human hepatocytes.
Chan K; Jensen NS; Silber PM; O'Brien PJ
Chem Biol Interact; 2007 Feb; 165(3):165-74. PubMed ID: 17229414
[TBL] [Abstract][Full Text] [Related]
4. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations.
Hewitt NJ; Lecluyse EL; Ferguson SS
Xenobiotica; 2007; 37(10-11):1196-224. PubMed ID: 17968743
[TBL] [Abstract][Full Text] [Related]
5. Hepatocytes in suspension.
Elaut G; Papeleu P; Vinken M; Henkens T; Snykers S; Vanhaecke T; Rogiers V
Methods Mol Biol; 2006; 320():255-63. PubMed ID: 16719397
[TBL] [Abstract][Full Text] [Related]
6. Definition of metabolism-dependent xenobiotic toxicity with co-cultures of human hepatocytes and mouse 3T3 fibroblasts in the novel integrated discrete multiple organ co-culture (IdMOC) experimental system: results with model toxicants aflatoxin B1, cyclophosphamide and tamoxifen.
Li AP; Uzgare A; LaForge YS
Chem Biol Interact; 2012 Jul; 199(1):1-8. PubMed ID: 22640811
[TBL] [Abstract][Full Text] [Related]
7. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
8. Accelerated cytotoxic mechanism screening of hydralazine using an in vitro hepatocyte inflammatory cell peroxidase model.
Tafazoli S; O'Brien PJ
Chem Res Toxicol; 2008 Apr; 21(4):904-10. PubMed ID: 18393451
[TBL] [Abstract][Full Text] [Related]
9. Phase I and phase II xenobiotic biotransformation in different inbred strains of rats: study in immobilized perfused hepatocytes.
Hynie S; Kren V; Mráz M; Farghali H
Folia Biol (Praha); 1998; 44(4):127-32. PubMed ID: 10732701
[TBL] [Abstract][Full Text] [Related]
10. Use of organotypical cultures of primary hepatocytes to analyse drug biotransformation in man and animals.
Bader A; Zech K; Crome O; Christians U; Ringe B; Pichlmayr R; Sewing KF
Xenobiotica; 1994 Jul; 24(7):623-33. PubMed ID: 7975727
[TBL] [Abstract][Full Text] [Related]
11. Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
Hewitt NJ; de Kanter R; LeCluyse E
Chem Biol Interact; 2007 May; 168(1):51-65. PubMed ID: 17239835
[TBL] [Abstract][Full Text] [Related]
12. Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals.
Rotroff DM; Beam AL; Dix DJ; Farmer A; Freeman KM; Houck KA; Judson RS; LeCluyse EL; Martin MT; Reif DM; Ferguson SS
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):329-46. PubMed ID: 20574906
[TBL] [Abstract][Full Text] [Related]
13. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances.
Navas JM; Segner H
Aquat Toxicol; 2006 Oct; 80(1):1-22. PubMed ID: 16950525
[TBL] [Abstract][Full Text] [Related]
14. Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes.
Lauer B; Tuschl G; Kling M; Mueller SO
Chem Biol Interact; 2009 Apr; 179(1):17-24. PubMed ID: 19022234
[TBL] [Abstract][Full Text] [Related]
15. Interspecies difference in liver-specific functions and biotransformation of testosterone of primary rat, porcine and human hepatocyte in an organotypical sandwich culture.
Langsch A; Giri S; Acikgöz A; Jasmund I; Frericks B; Bader A
Toxicol Lett; 2009 Aug; 188(3):173-9. PubMed ID: 19428196
[TBL] [Abstract][Full Text] [Related]
16. Hepatocytes cultured in alginate microspheres: an optimized technique to study enzyme induction.
Ringel M; von Mach MA; Santos R; Feilen PJ; Brulport M; Hermes M; Bauer AW; Schormann W; Tanner B; Schön MR; Oesch F; Hengstler JG
Toxicology; 2005 Jan; 206(1):153-67. PubMed ID: 15590115
[TBL] [Abstract][Full Text] [Related]
17. The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics.
Guillouzo A; Corlu A; Aninat C; Glaise D; Morel F; Guguen-Guillouzo C
Chem Biol Interact; 2007 May; 168(1):66-73. PubMed ID: 17241619
[TBL] [Abstract][Full Text] [Related]
18. Xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss): determination of trout hepatocellularity, optimization of cell concentrations and comparison of serum and serum-free incubations.
Han X; Mingoia RT; Nabb DL; Yang CH; Snajdr SI; Hoke RA
Aquat Toxicol; 2008 Aug; 89(1):11-7. PubMed ID: 18599132
[TBL] [Abstract][Full Text] [Related]
19. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
